Bioventix Plc: Results for the year ended 30 June 2022
www.bloomberg.com/press-releases/2022-10-24/bioventix-plc-results-for-the-year-ended-30-june-2022
1 Users
0 Comments
1 Highlights
0 Notes
Tags
Top Highlights
Our most significant revenue stream continues to come from the vitamin D antibody called vitD3.5H10. This antibody is used by a number of small, medium and large diagnostic companies around the world for use in vitamin D deficiency testing. Sales of vitD3.5H10 increased by 13% to £5.4 million which we believe reflects an improved downstream market for vitamin D testing following a degree of recovery from coronavirus pandemic effects.
Ready to highlight and find good content?
Glasp is a social web highlighter that people can highlight and organize quotes and thoughts from the web, and access other like-minded people’s learning.